Details of the Drug Reposition

General Information of This Drug (ID: DMHPZFD)

Drug Name	CC-90001 DMHPZFD

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)

2 Phase 1 Indication(s)

Indication Name	Indication ID	ICD-11	Status	REF
Idiopathic pulmonary fibrosis	DISZGA69	CB03.4	Phase 1	[1]
Fibrosis	DIS6FM27	GA14-GC01	Phase 1	[2]
------------------------------------------------------------------------------------

References

1	Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
2	ClinicalTrials.gov (NCT02110420) First-in-human Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Single and Multiple Ascending Doses of CC-90001. U.S. National Institutes of Health.